Clotilde K S Carlow

Title: Clotilde K S Carlow: Innovator in Biochemical Research

Introduction

Clotilde K S Carlow is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biochemical research, particularly in the study of proteins and their applications in immunodiagnosis.

Latest Patents

Carlow holds 2 patents, with his latest inventions focusing on critical advancements in the understanding of heartworm infections in mammals. One of his patents involves a 31-33 kDa glycoprotein from Dirofilaria immitis, known as DiT33. This glycoprotein is part of a family of putative pepsin inhibitors and plays a crucial role in monitoring antibody responses for immunodiagnosis of heartworm infections. His other patent relates to tyrosine-containing cyclophilins, which are used to identify compounds that can inhibit the enzymatic activity of these proteins, potentially leading to new treatments for resistant parasites.

Career Highlights

Carlow is associated with New England Biolabs, Inc., where he continues to push the boundaries of biochemical research. His work has been instrumental in developing methods that enhance the detection and treatment of parasitic infections.

Collaborations

He has collaborated with notable colleagues, including Francine B Perler and XiaQiang Hong, contributing to a rich environment of innovation and research.

Conclusion

Clotilde K S Carlow's work exemplifies the intersection of innovation and practical application in the field of biochemistry. His patents and ongoing research continue to impact the understanding and treatment of parasitic infections in mammals.